Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandra Bhagat PharmaBOM:542934 +4.98%65 Current Ratio is 1.50 as of Mar. 2026, which is 12% below its 10-year median of 1.71. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.19 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Chandra Bhagat Pharma ranks better than 57.98% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Chandra Bhagat Pharma's current ratio for the quarter that ended in Mar. 2026 was 1.50.
Chandra Bhagat Pharma has a current ratio of 1.50. It generally indicates good short-term financial strength.
The historical rank and industry rank for Chandra Bhagat Pharma's Current Ratio or its related term are showing as below:
BOM:542934'
s Current Ratio Range Over the Past 10 Years
Min: 1.38 Med: 1.71 Max: 2.16
Current: 1.5
During the past 10 years, Chandra Bhagat Pharma's highest Current Ratio was 2.16. The lowest was 1.38. And the median was 1.71.
BOM:542934's Current Ratio is ranked better than 57.98% of 119
companies
in the Medical Distribution industry
Industry Median: 1.4
vs BOM:542934: 1.50
Chandra Bhagat Pharma (BOM:542934) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Chandra Bhagat Pharma Current Ratio Related Terms
Chandra Bhagat Pharma Current Ratio Historical Data
* Premium members only.
The historical data trend for Chandra Bhagat Pharma's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542934 vs MCK, CAH, COR: Current Ratio Comparison
For the Medical Distribution subindustry, Chandra Bhagat Pharma's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Chandra Bhagat Pharma's Current Ratio distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandra Bhagat Pharma (BOM:542934) has a Current Ratio of 1.50 as of Mar. 2026. This is 12% below median its historical median of 1.71. Over the past decade, Chandra Bhagat Pharma's Current Ratio has ranged from 1.38 to 2.16. According to the industry distribution chart, Chandra Bhagat Pharma ranks #50 out of 119 companies in the Medical Distribution industry, placing it in the top 42%.
Is Chandra Bhagat Pharma's Current Ratio too high?
Chandra Bhagat Pharma's current Current Ratio of 1.50 is 12% below median its 10-year median of 1.71. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 2.16. The Medical Distribution industry median Current Ratio is 1.40. Chandra Bhagat Pharma's value of 1.50 is 7.1% above this industry median. Based on the distribution chart, Chandra Bhagat Pharma ranks #50 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's Current Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Chandra Bhagat Pharma ranks #50 out of 119 companies for Current Ratio. This puts Chandra Bhagat Pharma in the upper half of its industry. The industry median Current Ratio is 1.40. Chandra Bhagat Pharma's value of 1.50 is 7.1% above this benchmark. Historically, Chandra Bhagat Pharma's own Current Ratio has ranged from 1.38 to 2.16 over the past decade. While the company's 10-year median is 1.71 vs. the industry median of 1.40, Chandra Bhagat Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current Current Ratio of 1.50 is 7.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current Current Ratio is 1.50, which is 12% below median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.19, compared to a current price of ₹34.79 — trading 50.4% below its estimated fair value. The current Current Ratio is 1.50, which is 12% below median its 10-year median of 1.71 and 7.1% above the Medical Distribution industry median of 1.40. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current Current Ratio is 1.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?
Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued.
The current stock price of ₹34.79 is trading 50.4% below its estimated GF Value™ of ₹70.19.
GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.
Key valuation signals for BOM:542934:
Current Ratio: 1.50 (12% below median its 10-year median of 1.71)
GF Value™: ₹70.19 vs. price of ₹34.79 (50.4% below fair value)
Industry Position: 7.1% above the Medical Distribution median (#50 of 119)
No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score
Get the complete analysis for BOM:542934
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542934 has been successfully added to your 
